Tan Hendrick, Stewart James, Ruschin Mark, Wang Michael H, Myrehaug Sten, Tseng Chia-Lin, Detsky Jay, Husain Zain, Chen Hanbo, Sahgal Arjun, Soliman Hany
Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada.
GenesisCare, Perth, WA, Australia.
J Neurooncol. 2022 Feb;156(3):569-577. doi: 10.1007/s11060-021-03938-w. Epub 2022 Jan 3.
PURPOSE/OBJECTIVE(S): This study examined changes in the clinical target volume (CTV) and associated clinical implications on a magnetic resonance imaging linear accelerator (MR LINAC) during hypofractionated stereotactic radiotherapy (HSRT) to resected brain metastases. In addition, the suitability of using T2/FLAIR (T2f) sequence to define CTV was explored by assessing contouring variability between gadolinium-enhanced T1 (T1c) and T2f sequences.
MATERIALS/METHODS: Fifteen patients treated to either 27.5 or 30 Gy with five fraction HSRT were imaged with T1c and T2f sequences during treatment; T1c was acquired at planning (FxSim), and fraction 3 (Fx3), and T2f was acquired at FxSim and all five fractions. The CTV were contoured on all acquired images. Inter-fraction cavity dynamics and CTV contouring variability were quantified using absolute volume, Dice similarity coefficient (DSC), and Hausdorff distance (HD) metrics.
The median CTV on T1c and T2f sequences at FxSim were 12.0cm (range, 1.2-30.1) and 10.2cm (range, 2.9-27.9), respectively. At Fx3, the median CTV decreased in both sequences to 9.3cm (range, 3.7-25.9) and 8.6cm (range, 3.3-22.5), translating to a median % relative reduction of - 11.4% on T1c (p = 0.009) and - 8.4% on T2f (p = 0.032). We observed a median % relative reduction in CTV between T1c and T2f at FxSim of - 6.0% (p = 0.040). The mean DSC was 0.85 ± 0.10, and the mean HD was 5.3 ± 2.7 mm when comparing CTV on T1c and T2f at FxSim.
Statistically significant reductions in cavity CTV was observed during HSRT, supporting the use of MR image guided radiation therapy and treatment adaptation to mitigate toxicity. Significant CTV contouring variability was seen between T1c and T2f sequences. Trial registration NCT04075305 - August 30, 2019.
本研究探讨了在对切除的脑转移瘤进行大分割立体定向放射治疗(HSRT)期间,磁共振成像直线加速器(MR LINAC)上临床靶体积(CTV)的变化及相关临床意义。此外,通过评估钆增强T1(T1c)序列和T2/液体衰减反转恢复(T2f)序列之间的轮廓勾画变异性,探讨了使用T2f序列定义CTV的适用性。
15例接受5次分割、剂量为27.5或30 Gy的HSRT治疗的患者在治疗期间采用T1c和T2f序列进行成像;T1c序列在计划时(FxSim)和第3次分割(Fx3)时采集,T2f序列在FxSim和所有5次分割时采集。在所有采集的图像上勾画CTV。使用绝对体积、骰子相似系数(DSC)和豪斯多夫距离(HD)指标对分割间空洞动态变化和CTV轮廓勾画变异性进行量化。
FxSim时T1c和T2f序列上CTV的中位数分别为12.0cm(范围1.2 - 30.1)和10.2cm(范围2.9 - 27.9)。在Fx3时,两个序列上CTV的中位数均下降至9.3cm(范围3.7 - 25.9)和8.6cm(范围3.3 - 22.5),T1c序列上相对中位数减少了-11.4%(p = 0.009),T2f序列上减少了-8.4%(p = 0.032)。我们观察到FxSim时T1c和T2f之间CTV的相对中位数减少了-6.0%(p = 0.040)。比较FxSim时T1c和T2f上的CTV,平均DSC为0.85±0.10,平均HD为5.3±2.7mm。
在HSRT期间观察到空洞CTV有统计学意义的减少,支持使用磁共振图像引导放射治疗和治疗适应性调整以减轻毒性。T1c和T2f序列之间观察到显著的CTV轮廓勾画变异性。试验注册号NCT04075305 - 2019年8月30日。